Read what Key Opinion Leaders have to say about Pivotal 4pharma.
Professor Anthony Howell
“I have worked with Tim Sheldon over many years in his various capacities at AstraZeneca. These have included drug development, protocol design, congress presentations and satellite meetings, preparing trial data for publication and setting up advisory boards.”
Read more
Dr John E Pippen Jr
“I am writing in support of Pivotal 4pharma, and its originator Tim Sheldon. Over the past 10 years, I have had the opportunity to work with Tim on a variety of programs related to breast cancer.”
Read more
Professor Michael Baum
“I have known, and worked with Tim Sheldon from AstraZeneca for over 10 years, working on a variety programmes and initiatives. It was as Chairman of the ATAC steering Committee that brought me most contact and knowledge of Tim.”
Read more
Professor W R Miller
“I have known Tim Sheldon for over 10 years. During this time he was the AstraZeneca Global Publications Manager and we were involved in numerous initiatives and programmes.”
Read more
Professor Jean-Marc A. Nabholtz
“I have known Mr. Tim Sheldon for more than 15 years. We have worked together over the years within the context of the ATAC Steering Commitee, AstraZeneca stand-alone meetings and symposia as well as through his publication support on various Arimidex breast cancer papers (Journal of Clinical Oncology, Cancer, Lancet).”
Read more
Professor Aman U.Buzdar
“I am writing in support of Tim Sheldon who will soon be leaving AstraZeneca to start up his own company Pivotal 4pharma. I first worked with Tim in the mid 1990’s on publication and communication initiatives related to the first Arimidex advanced breast cancer trials (versus megestrol acetate). ”
Read more
John F R Robertson
“ have known Tim Sheldon for almost 20 years and have worked with him in numerous contexts as his role within AstraZeneca grew over that time period. ”
Read more